AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Recent evidence indicates that glutamate homeostasis and neurotransmission are altered in major depressive disorder, but the nature of the disruption and the mechanisms by which it contributes to the syndrome are unclear. Glutamate can act via AMPA, NMDA, or metabotropic receptors. Using targeted mutagenesis, we demonstrate here that mice with deletion of the main AMPA receptor subunit GluR‐A represent a depression model with good face and construct validity, showing behavioral and neurochemical features of depression also postulated for human patients. GluR‐A −/− mice display increased learned helplessness, decreased serotonin and norepinephrine levels, and disturbed glutamate ho‐meostasis with increased glutamate levels and increased NMDA receptor expression. These results correspond well with current concepts regarding the role of AMPA and NMDA receptors in depression, postulating that compounds that augment AMPA receptor signaling or decrease NMDA receptor functions have antidepressant effects. GluR‐A −/− mice represent a model to investigate the pathophysiology underlying the depressive phenotype and to identify changes in neural plasticity and resilience evoked by the genetic alterations in glutamatergic function. Furthermore, GluR‐A −/− mice may be a valuable tool to study biological mechanisms of AMPA receptor modulators and the efficacy of NMDA antagonists in reducing behavioral or biochemical changes that correlate with increased helplessness.—Chourbaji, S., Vogt, M. A., Fumagalli, F., Sohr, R., Frasca, A., Brandwein, C, Hörtnagl, H., Riva, M. A., Sprengel, R., Gass, P. AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression. FASEB J. 22, 3129–3134 (2008)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Global deletion of the gene for the GluA1 subunit of the AMPAR, for example, results in a depressionlike phenotype in the learned helplessness test [113].”
From Plasticity of synapses and reward circuit function in the genesis and treatment of depression (2023) · cites this paper as [113]
Citations
Cites
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
The ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198 · cited 1×
“Rodent models can provide important tools for elucidating the pathophysiology of psychiatric diseases (10).”
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Plasticity of the Hippocampus: Adaptation to Chronic Stress and Allostatic Load
McEwen, B. S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05830.x · Cited by 873
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Importance of AMPA Receptors for Hippocampal Synaptic Plasticity But Not for Spatial Learning
Zamanillo, D., Sprengel, R., Hvalby, Ø., Jensen, V., Burnashev, N., Rozov, A., Kaiser, K. M. M., Köster, H. J., Borchardt, T., Worley, P., et al. (1999) · Science · doi:10.1126/science.284.5421.1805 · Cited by 791 · cited 3×
“for synaptic plasticity in the hippocampus, a limbic structure important for emotional behavior ( 11 ).”
BackgroundResultInfluentialSelf-citationFunctional antagonists at the NMDA receptor complex exhibit antidepressant actions
Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90204-j · Cited by 785
The Yin and Yang of NMDA receptor signalling
Hardingham, G. E., & Bading, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00040-1 · Cited by 620
DETERMINATION OF CATECHOLAMINES IN RAT BRAIN PARTS BY REVERSE‐PHASE ION‐PAIR LIQUID CHROMATOGRAPHY
Felice, L. J., Felice, J. D., & Kissinger, P. T. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb06573.x · Cited by 580
Glutamate as a therapeutic target in psychiatric disorders
Javitt, D. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001551 · Cited by 524
Garcia, L. S. B., Comim, C. M., Valvassori, S. S., Réus, G. Z., Barbosa, L. M., Andreazza, A. C., Stertz, L., Fries, G. R., Gavioli, E. C., Kapczinski, F., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.027 · Cited by 454
Aston, C., Jiang, L., & Sokolov, B. P. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001565 · Cited by 427
Glutamate and Depression: Clinical and Preclinical Studies
PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.016 · Cited by 408
Monoamine dysfunction and the pathophysiology and treatment of depression.
Charney, D. S. (1998) · PubMed · Cited by 395
Ridder, S., Chourbaji, S., Hellweg, R., Urani, A., Zacher, C., Schmid, W., Zink, M., Hörtnagl, H., Flor, H., Henn, F. A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0736-05.2005 · Cited by 382 · cited 1×
“Behavioral experiments were essentially carried out as described earlier (12).”
MethodSelf-citationStress and hippocampal plasticity: implications for the pathophysiology of affective disorders
McEwen, B. S., & Magarinos, A. M. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.266 · Cited by 349
An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J., Sporn, J., Denicoff, K. K., Luckenbaugh, D., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 324
Newton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10883.2002 · Cited by 313
Learned helplessness and animal models of depression
Maier, S. (1984) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(84)90120-9 · Cited by 309
Beyond Monoamines: Glutamatergic Function in Mood Disorders
Kugaya, A., & Sanacora, G. (2005) · CNS Spectrums · doi:10.1017/s1092852900010403 · Cited by 290
Bonanno, G., Giambelli, R., Raiteri, L., Tiraboschi, E., Zappettini, S., Musazzi, L., Raiteri, M., Racagni, G., & Popoli, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5033-04.2005 · Cited by 234
The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder
Pittenger, C., Sanacora, G., & Krystal, J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363267 · Cited by 203
Molecular biology of glutamate receptors
Schoepfer, R., Monyer, H., Sommer, B., Wisden, W., Sprengel, R., Kuner, T., Lomelí, H., Herb, A., Köhler, M. G., Burnashev, N., et al. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90076-0 · Cited by 158
Self-citationNudmamud‐Thanoi, S., & Reynolds, G. P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.035 · Cited by 150
Sperk, G. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb08708.x · Cited by 136
AMPA Receptors in the Therapeutic Management of Depression
Bleakman, D., Alt, A., & Witkin, J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780363258 · Cited by 114
Trullás, R., Jackson, B., & Skolnick, P. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90317-1 · Cited by 104
Bannerman, D. M., Deacon, R. M. J., Brady, S., Bruce, A., Sprengel, R., Seeburg, P. H., & Rawlins, J. N. P. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.3.643 · Cited by 102
Self-citationSperk, G., Berger, M. L., Hörtnagl, H., & Hornykiewicz, O. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90046-7 · Cited by 88
Self-citationPiepponen, P. T., & Skujiņš, A. (2001) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(01)00156-6 · Cited by 79
Fumagalli, F., Frasca, A., Racagni, G., & Riva, M. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043786 · Cited by 69
Self-citationGlutamate and anxiety disorders
Amiel, J. M., & Mathew, S. J. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0033-7 · Cited by 53
Beyond monoamine-based therapies: clues to new approaches.
Skolnick, P. (2002) · PubMed · Cited by 46
Monoamine Receptors in an Animal Model of Affective Disorder
Martin, J. V., Edwards, E., Johnson, J. O., & Henn, F. A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb03117.x · Cited by 44
Adjunctive Lamotrigine Treatment for Major Depression
MALTESE, T. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1833 · Cited by 30
Research works printed but not linked: 1
- 10.1016/s0278-5846(84)80032-9 · doi:10.1016/s0278-5846(84)80032-9 · Paper page
Cited by
The neurobiology of depression and antidepressant action
Willner, P., Scheel-Krüger, J., & Belzung, C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.007 · Cited by 519
Neural Mechanisms of Stress Resilience and Vulnerability
Franklin, T. B., Saab, B. J., & Mansuy, I. M. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.016 · Cited by 500
Neuroinflammation and comorbidity of pain and depression
Walker, A. K., Kavelaars, A., Heijnen, C. J., & Dantzer, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008144 · Cited by 460
“These changes were associated with altered glutamatergic function and increased NMDA receptor expression (Chourbaji et al., 2008).”
BackgroundMcEwen, B. S., Chattarji, S., Diamond, D. M., Jay, T. M., Reagan, L. P., Svenningsson, P., & Fuchs, E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.80 · Cited by 406
“Chourbaji S, Vogt MA, Fumagalli F, Sohr R, Frasca A, Brandwein C, Hortnagl H, Riva MA, Sprengel R, Gass P. AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression.”
BackgroundEmerging role of glutamate in the pathophysiology of major depressive disorder
Hashimoto, K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.005 · Cited by 381
Metadata
- Authors
- Chourbaji, S., Vogt, M. A., Fumagalli, F., Sohr, R., Frasca, A., Brandwein, C., Hörtnagl, H., Riva, M. A., Sprengel, R., & Gass, P.
- Affiliations
- Heidelberg University (DE)
- University of Milan (IT)
- Charité – Universitätsmedizin Berlin (DE)
- Max Planck Society (DE)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-05-20
- Volume
- 22
- Issue
- 9
- Pages
- 3129-3134
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1984754469
- Cited by
- 144
- References
- 36
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 3 · 2022: 11 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 9 · 2015: 11 · 2014: 9 · 2013: 15 · 2012: 6
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (GA427/8–1, SP602/ 2–1)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- AMPA receptors, knockout mice, depression model, glutamate homeostasis, NMDA receptor, learned helplessness, serotonin, norepinephrine, antidepressant mechanism, NMDA receptor antagonists, neuroplasticity, resilience
- MeSH terms
- Animals, Major Depressive Disorder, Disease Models, Animal, Helplessness, Learned, Hippocampus, Male, Norepinephrine, Serotonin, Receptors, N-Methyl-D-Aspartate, Receptors, AMPA, Mice, Knockout, Glutamic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.